Skylight Health Receives Conditional Approval of TSX Venture Listing
- Skylight Health has been granted conditional approval for listing on the TSX Venture Exchange
- Company expects to commence trading on the TSX Venture in January 2021
- Company will continue to trade under the symbol “SHG” on the TSX Venture
TORONTO, ON – December 15, 2020 – Skylight Health Group Inc (CSE:SHG; OTCQX:SHGFF) (“SHG” or the “Company”), one of the largest multi-specialty healthcare systems in the United States, is pleased to announce that it has received conditional approval to list its common shares on the TSX Venture Exchange (“TSX-V”), and will concurrently delist its common shares from the Canadian Securities Exchange (“CSE”). To ensure continued trading of the Company’s common shares, the Company intends to seamlessly arrange for the simultaneous delisting of its common shares from the CSE and subsequent commencement of trading on the TSX-V.
“Graduating to the TSX-V is yet another milestone achieved as we continue to execute our focused growth plan of becoming one of the largest US integrated healthcare systems,” said Prad Sekar, CEO of Skylight Health. “We look forward to the TSX-V providing us a larger platform for growth, institutional coverage and border liquidity as we continue to aggressively execute against our 2021 business plan.”
Skylight Health’s common shares will trade on the TSX Venture under symbol “SHG”.
The Company has also issued 500,000 options at a price of $1.11 to certain consultants for services delivered.
